Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Metabolic Genetics

Building Your Care Team & First Visit Prep

At a Glance

Building a care team for Citrullinemia Type I (CTLN1) requires specialists experienced in urea cycle disorders. Your core team must include a metabolic geneticist and dietitian, ideally at a medical center with 24/7 emergency dialysis capabilities.

Building a specialized care team is one of the most important steps in managing Citrullinemia Type I (CTLN1). Because this condition affects multiple systems in the body and can change rapidly, you need a group of experts who communicate with each other and with you [1][2].

Your Core Care Team

A multidisciplinary approach is linked to better survival and a higher quality of life for children with urea cycle disorders [2][3].

  • Metabolic Geneticist: This is your “quarterback.” They are doctors who specialize in how the body’s chemistry works. They coordinate the overall treatment plan [1][4].
  • Metabolic Dietitian: This specialist is essential. They calculate the exact amount of protein your child needs to grow while keeping ammonia levels safe [5].
  • Genetic Counselor: They help you understand the inheritance of CTLN1 and discuss risks for future pregnancies [6].
  • Social Worker or Care Coordinator: These professionals help with insurance approvals for expensive formulas and can connect you with financial assistance [7].
  • Specialty Backup: Your team may also include a hepatologist (liver doctor) for transplant discussions or a neurologist to monitor brain development [8][9].

Preparing for Your First Appointment

Arriving prepared ensures you get the most out of your specialized time [10].

Documents to Bring

Collect these “physical artifacts” in a dedicated binder or digital folder:

  • Newborn Screening (NBS) Results: The original report that flagged the elevated citrulline [11].
  • Hospital Discharge Summaries: Summaries that list treatments like dialysis or IV nitrogen scavengers [12].
  • Laboratory Panels: Any recent blood work, especially ammonia levels and “Plasma Amino Acids” [5][10].
  • Current Intake Log: A 3-day record of exactly what your child eats and drinks.

Vetting Your Specialists

Not all doctors have experience with Urea Cycle Disorders. It is important to ensure your team has specific expertise [2]. Consider asking these questions:

  1. Experience: “How many other patients with urea cycle disorders do you currently manage?”
  2. Emergency Dialysis Access: “Does this medical center have on-site, 24/7 capability for pediatric continuous renal replacement therapy (CRRT) or hemodialysis?” (Many community hospitals do not, which forces dangerous delays due to emergency transfers).
  3. Emergency Access: “If my child has a fever at 2:00 AM, how do I reach a metabolic specialist who knows our case?” [12]

Establishing a “Medical Home”

The goal is to create a “medical home”—a primary center where all your child’s records live and where you feel empowered to ask questions [1][10].


Return to Home Page

Common questions in this guide

What specialists do I need on my Citrullinemia Type I care team?
Your core care team should include a metabolic geneticist, a metabolic dietitian, a genetic counselor, and a social worker. Depending on your child's needs, you may also see a hepatologist or a neurologist.
Why is a metabolic dietitian important for CTLN1?
A metabolic dietitian calculates the exact amount of protein your child needs to grow properly while keeping their ammonia levels in a safe range. They are critical for managing your child's highly specialized diet and formula.
What documents should I bring to my first metabolic appointment?
You should bring your child's newborn screening results, any hospital discharge summaries, recent laboratory panels including ammonia levels, and a 3-day log of exactly what your child eats and drinks.
Why is it important to ask a hospital about emergency dialysis access?
It is vital to ask if the medical center has on-site, 24/7 capability for pediatric dialysis or continuous renal replacement therapy (CRRT). CTLN1 emergencies can happen rapidly, and lacking on-site dialysis can cause dangerous transfer delays.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Are you or is this center part of the Urea Cycle Disorders Consortium (UCDC)?
  2. 2.How many patients with Citrullinemia Type I (CTLN1) are currently under your care?
  3. 3.Does this medical center have on-site, 24/7 capability for pediatric continuous renal replacement therapy (CRRT) or hemodialysis?
  4. 4.Does your center have a 24/7 on-call metabolic specialist I can reach during an emergency?
  5. 5.Will I have direct access to a metabolic dietitian for formula adjustments and dietary planning at every visit?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision.

    Häberle J, Burlina A, Chakrapani A, et al.

    Journal of inherited metabolic disease 2019; (42(6)):1192-1230 doi:10.1002/jimd.12100.

    PMID: 30982989
  2. 2

    Challenges in the diagnosis and management of urea cycle disorders in Romanian children.

    Pop TL, Grama A, Miclea D, et al.

    Medicine and pharmacy reports 2021; (94(Suppl No 1)):S36-S39 doi:10.15386/mpr-2226.

    PMID: 34527907
  3. 3

    Urea cycle disorders and indications for liver transplantation.

    García Vega M, Andrade JD, Morais A, et al.

    Frontiers in pediatrics 2023; (11()):1103757 doi:10.3389/fped.2023.1103757.

    PMID: 36937980
  4. 4

    Acute Illness Protocol for Urea Cycle Disorders.

    Rodan LH, Aldubayan SH, Berry GT, Levy HL

    Pediatric emergency care 2018; (34(6)):e115-e119 doi:10.1097/PEC.0000000000001298.

    PMID: 29135898
  5. 5

    Urea Cycle Related Amino Acids Measured in Dried Bloodspots Enable Long-Term In Vivo Monitoring and Therapeutic Adjustment.

    Baruteau J, Khalil Y, Grunewald S, et al.

    Metabolites 2019; (9(11)) doi:10.3390/metabo9110275.

    PMID: 31718089
  6. 6

    Case Report: From coma to genetic insights: identification of a novel pathogenic variant in Chinese neonatal CTLN1.

    Deng L, Liu Y, Chen K, et al.

    Frontiers in pediatrics 2025; (13()):1593427 doi:10.3389/fped.2025.1593427.

    PMID: 40837674
  7. 7

    Childhood-onset hereditary spastic paraplegia and its treatable mimics.

    Ebrahimi-Fakhari D, Saffari A, Pearl PL

    Molecular genetics and metabolism 2022; (137(4)):436-444 doi:10.1016/j.ymgme.2021.06.006.

    PMID: 34183250
  8. 8

    Management of late onset urea cycle disorders-a remaining challenge for the intensivist?

    Redant S, Empain A, Mugisha A, et al.

    Annals of intensive care 2021; (11(1)):2 doi:10.1186/s13613-020-00797-y.

    PMID: 33409766
  9. 9

    Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan.

    Kido J, Matsumoto S, Häberle J, et al.

    Journal of inherited metabolic disease 2021; (44(6)):1311-1322 doi:10.1002/jimd.12415.

    PMID: 34232532
  10. 10

    A holistic approach to the patients/ Families with inborn errors of metabolism.

    Burgard P

    Journal of mother and child 2020; (24(2)):65-72 doi:10.34763/jmotherandchild.20202402si.2004.000010.

    PMID: 33179604
  11. 11

    Expanded Newborn Screening for Inborn Errors of Metabolism in Hong Kong: Results and Outcome of a 7 Year Journey.

    Belaramani KM, Chan TCH, Hau EWL, et al.

    International journal of neonatal screening 2024; (10(1)) doi:10.3390/ijns10010023.

    PMID: 38535127
  12. 12

    A Case of Atypical Adult Presentation of Urea Cycle Disorder.

    Wang B, Jha P

    WMJ : official publication of the State Medical Society of Wisconsin 2019; (118(2)):98-100.

    PMID: 31532938

This page is for informational purposes only and does not replace professional medical advice. Always consult your specialized metabolic care team for decisions regarding Citrullinemia Type I management and emergencies.

Get notified when new evidence is published on Citrullinemia type I.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.